Latest Muscle Pharm Corp (MSLP) Headlines
USA Wrestling Names MusclePharm as Its Exclusive Official Nutritional Supplement Provider
Marketwire - Thu Mar 06, 7:15AM CST
USA Wrestling, the national governing body for wrestling in the United States, has signed MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, as its exclusive official nutritional supplement provider.
The Arnold Schwarzenegger Blueprint by MusclePharm Debuts at BodyBuilding.com
Marketwire - Thu Feb 27, 7:04AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced the launch of The Arnold Schwarzenegger(TM) Blueprint at BodyBuilding.com leading up to the annual Arnold Sports Festival in Columbus, Ohio from Feb. 27 - March 2, 2014.
MusclePharm Sports Science Institute Hosts RockTape Fascial Movement Taping Workshop
Marketwire - Wed Feb 26, 12:30PM CST
MusclePharm Corporation, a leading international, award-winning sports nutrition company, recently hosted a RockTape Fascial Movement Taping workshop to provide training and certification for kinesiology taping techniques. Fascial Movement Taping is a technique based on muscles acting as a chain to create efficient, fluid patterns.
MusclePharm CEO Issues Update Letter to Shareholders
Marketwire - Wed Jan 29, 8:01AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading, award-winning sports nutrition company, today issued the following letter to shareholders from its Chairman and CEO, Brad Pyatt:
MusclePharm Corporation acquires BioZone Pharmaceuticals' assets
M2 - Tue Jan 07, 5:52AM CST
Sports nutrition company MusclePharm Corporation (OTCQB:MSLP) revealed on Monday the completion of the acquisition of essentially all assets of BioZone Pharmaceuticals Inc (OTCBB: BZNE) and its subsidiaries, for 1.2m shares of MusclePharm stock.
MusclePharm Completes Acquisition of Substantially All Assets of BioZone Pharmaceuticals
Marketwire - Mon Jan 06, 7:31AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has completed the acquisition of essentially all assets of BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) and its subsidiaries, for 1.2 million shares of MusclePharm stock.
MusclePharm Names PondelWilkinson as Investor Relations Counsel
Marketwire - Tue Dec 31, 7:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has retained PondelWilkinson Inc. as investor relations counsel.
BioZone Pharmaceuticals, Inc. Completes Balance Sheet Enhancement
Marketwire - Tue Dec 24, 7:00AM CST
BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) announced today that it has completed an enhancement of its balance sheet by eliminating remaining outstanding convertible notes. In the recent transaction, holders of convertible notes with approximately $2.5 million of principal and accrued interest exchanged their securities for shares of common stock. OPKO Health Inc. (NYSE: OPK), a principal shareholder of BioZone Pharmaceuticals and one of the note holders that converted its notes, expressed the view through its Chairman and CEO, Dr. Phillip Frost, that it is optimistic that the planned acquisition of Cocrystal Discovery will enhance shareholder value and enhance BioZone's future prospects as a high growth biotech company.
MusclePharm Announces New $5 Million Share Repurchase Program
Marketwire - Tue Dec 10, 9:01AM CST
MusclePharm Corporation (OTCQB: MSLP) (the "Company"), a leading international, award-winning sports nutrition company, announced that its Board of Directors has approved a new 1 year, $5 million program to repurchase shares of MusclePharm's common stock.
BioZone Pharmaceuticals, Inc. Enhances Balance Sheet
Marketwire - Mon Dec 02, 7:46AM CST
BioZone Pharmaceuticals, Inc. (OTCQB: BZNE) announced today that it has enhanced its balance sheet significantly by eliminating outstanding convertible preferred stock. In the recent transaction, holders of convertible preferred stock, with a stated value of $3.5 million and a 10% dividend, exchanged their securities for shares of common stock. Key holders expressed the view that the recently announced merger with Cocrystal Discovery, Inc. is a significant positive development for the Company.
Ultimate Fighting Championship® (UFC), MusclePharm® Renew Partnership
PR Newswire - Mon Dec 02, 6:30AM CST
The Ultimate Fighting Championship® announced a multi-year renewal with MusclePharm® Corporation (OTCQB: MSLP) a leading international, award-winning sports nutrition company. In addition to branding in the hallowed Octagon®, MusclePharm will be featured in a variety of UFC programming elements ranging from national television broadcasts to Pay-Per-Views and across UFC's digital platforms. The sponsorship also involves special events and the use of official marks and logos for consumer retail promotions including a special Octagon-shaped Fight Pack.
MusclePharm Sports Science Center Hosts Top Researchers, Coaches, Practitioners, Students for National Strength and Conditioning Association Event
PR Newswire - Tue Nov 26, 6:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, recently hosted the National Strength and Conditioning Association (NSCA) Colorado State Clinic which featured leading U.S. researchers and speakers including Dr. Jordan Moon, Colorado State Director, NSCA and Dr. Eric Serrano, Chief Medical Officer, of MusclePharm and Director of the company's Research Institute.
LEVI & KORSINSKY, LLP Notifies Investors of BIOZONE PHARMACEUTICALS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with the Sale of Assets to MusclePharm Corporation
Business Wire - Tue Nov 19, 12:11PM CST
Levi & Korsinsky notifies investors of Biozone Pharmaceuticals, Inc. ("Biozone" or the "Company") (Nasdaq: BZNE) of possible breaches of fiduciary duty and other violations of state law in connection with the sale of Company assets to MusclePharm Corporation ("MusclePharm") (OTCQB: MSLP).
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Biozone Pharmaceuticals, Inc. Proposed Asset Sale to MusclePharm Corporation
Business Wire - Tue Nov 19, 7:17AM CST
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether the Board of Directors of Biozone Pharmaceuticals, Inc. (Nasdaq: BZNE) breached its fiduciary duties in connection with the Company's proposed sale of assets to MusclePharm Corporation (OTCQB: MSLP).
MusclePharm's Award Winning Amino 1 To Be Available at Costco January 2014
PR Newswire - Tue Nov 19, 6:30AM CST
MusclePharm Corporation (OTCQB: MSLP) a leading international, award-winning sports nutrition company, announced today that its popular Amino 1 recovery and hydration sports drink will be available at 150 Costco locations nationwide mid-January 2014.
MusclePharm Announces Results of Audit Committee Review - No Restatement Required
Marketwire - Fri Nov 15, 6:00AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm", or the "Company"), a leading international, award-winning sports nutrition company, announced today that the Audit Committee of its Board of Directors has reviewed certain matters that are the subject of the SEC investigation disclosed in a Form 8-K filed on September 30, 2013 and concluded that no restatement of prior periods' financial statements is required. The matters reviewed included a loss of $2.1 million recorded in 2011 in regard to settlement of accounts payable, the reserve established for previously disclosed litigation initiated against the Company by William Bossung (the "Bossung Litigation"), six proposed adjustment entries made by the auditors in 2012 which were approved by the Audit Committee (the effect of which were below the materiality threshold of the audit) and not made by the Company in that year, and the amounts disclosed as executive perquisites in the Annual Reports on Form 10-K for the fiscal years ended 2010, 2011 and 2012.
MusclePharm Third Quarter Gross Sales Increased 51% to a Record $31.1 Million
Marketwire - Thu Nov 14, 3:23PM CST
MusclePharm Corporation (OTCQB: MSLP) (the "Company", or "MusclePharm"), a leading international, award-winning sports nutrition company, announced today its financial results for the third quarter ended September 30, 2013 ("Q3 2013").
Exclusive Insight on ITEN, MSLP and AMBS
ACCESSWIRE - Thu Nov 14, 3:20AM CST
CodeSmart Holdings, Inc. (OTC:ITEN), Muscle Pharm Corp. (OTC:MSLP) and Amarantus Bioscience Holdings, Inc (OTC:AMBS) have been added to our watch list.
Biozone Announces First Step in Strategic Transition
Marketwire - Wed Nov 13, 2:19PM CST
Biozone Pharmaceuticals, Inc. (OTCQB: BZNE), a manufacturer of over-the-counter (OTC) pharmaceuticals, and skin care, cosmetic and beauty products, and developer of proprietary drug delivery platforms, issued the following Letter to Shareholders from Elliot Maza, Chief Executive Officer and CFO of the company.
MusclePharm to Acquire BioZone Pharmaceuticals' QuSomes(R) Technology and Manufacturing Facilities
Marketwire - Wed Nov 13, 7:03AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm"), a leading international, award-winning sports nutrition company, announced today it has signed a definitive asset purchase agreement with BioZone Pharmaceuticals, Inc. ("BioZone") to acquire substantially all of the assets of BioZone and its subsidiaries.
USA Wrestling Names MusclePharm as Its Exclusive Official Nutritional Supplement Provider
Marketwire - Thu Mar 06, 7:15AM CST
USA Wrestling, the national governing body for wrestling in the United States, has signed MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, as its exclusive official nutritional supplement provider.
The Arnold Schwarzenegger Blueprint by MusclePharm Debuts at BodyBuilding.com
Marketwire - Thu Feb 27, 7:04AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced the launch of The Arnold Schwarzenegger(TM) Blueprint at BodyBuilding.com leading up to the annual Arnold Sports Festival in Columbus, Ohio from Feb. 27 - March 2, 2014.
MusclePharm Sports Science Institute Hosts RockTape Fascial Movement Taping Workshop
Marketwire - Wed Feb 26, 12:30PM CST
MusclePharm Corporation, a leading international, award-winning sports nutrition company, recently hosted a RockTape Fascial Movement Taping workshop to provide training and certification for kinesiology taping techniques. Fascial Movement Taping is a technique based on muscles acting as a chain to create efficient, fluid patterns.
MusclePharm CEO Issues Update Letter to Shareholders
Marketwire - Wed Jan 29, 8:01AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading, award-winning sports nutrition company, today issued the following letter to shareholders from its Chairman and CEO, Brad Pyatt:
MusclePharm Corporation acquires BioZone Pharmaceuticals' assets
M2 - Tue Jan 07, 5:52AM CST
Sports nutrition company MusclePharm Corporation (OTCQB:MSLP) revealed on Monday the completion of the acquisition of essentially all assets of BioZone Pharmaceuticals Inc (OTCBB: BZNE) and its subsidiaries, for 1.2m shares of MusclePharm stock.
MusclePharm Completes Acquisition of Substantially All Assets of BioZone Pharmaceuticals
Marketwire - Mon Jan 06, 7:31AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has completed the acquisition of essentially all assets of BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) and its subsidiaries, for 1.2 million shares of MusclePharm stock.
MusclePharm Names PondelWilkinson as Investor Relations Counsel
Marketwire - Tue Dec 31, 7:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, today announced that it has retained PondelWilkinson Inc. as investor relations counsel.
BioZone Pharmaceuticals, Inc. Completes Balance Sheet Enhancement
Marketwire - Tue Dec 24, 7:00AM CST
BioZone Pharmaceuticals, Inc. (OTCBB: BZNE) announced today that it has completed an enhancement of its balance sheet by eliminating remaining outstanding convertible notes. In the recent transaction, holders of convertible notes with approximately $2.5 million of principal and accrued interest exchanged their securities for shares of common stock. OPKO Health Inc. (NYSE: OPK), a principal shareholder of BioZone Pharmaceuticals and one of the note holders that converted its notes, expressed the view through its Chairman and CEO, Dr. Phillip Frost, that it is optimistic that the planned acquisition of Cocrystal Discovery will enhance shareholder value and enhance BioZone's future prospects as a high growth biotech company.
MusclePharm Announces New $5 Million Share Repurchase Program
Marketwire - Tue Dec 10, 9:01AM CST
MusclePharm Corporation (OTCQB: MSLP) (the "Company"), a leading international, award-winning sports nutrition company, announced that its Board of Directors has approved a new 1 year, $5 million program to repurchase shares of MusclePharm's common stock.
BioZone Pharmaceuticals, Inc. Enhances Balance Sheet
Marketwire - Mon Dec 02, 7:46AM CST
BioZone Pharmaceuticals, Inc. (OTCQB: BZNE) announced today that it has enhanced its balance sheet significantly by eliminating outstanding convertible preferred stock. In the recent transaction, holders of convertible preferred stock, with a stated value of $3.5 million and a 10% dividend, exchanged their securities for shares of common stock. Key holders expressed the view that the recently announced merger with Cocrystal Discovery, Inc. is a significant positive development for the Company.
Ultimate Fighting Championship® (UFC), MusclePharm® Renew Partnership
PR Newswire - Mon Dec 02, 6:30AM CST
The Ultimate Fighting Championship® announced a multi-year renewal with MusclePharm® Corporation (OTCQB: MSLP) a leading international, award-winning sports nutrition company. In addition to branding in the hallowed Octagon®, MusclePharm will be featured in a variety of UFC programming elements ranging from national television broadcasts to Pay-Per-Views and across UFC's digital platforms. The sponsorship also involves special events and the use of official marks and logos for consumer retail promotions including a special Octagon-shaped Fight Pack.
MusclePharm Sports Science Center Hosts Top Researchers, Coaches, Practitioners, Students for National Strength and Conditioning Association Event
PR Newswire - Tue Nov 26, 6:30AM CST
MusclePharm Corporation (OTCQB: MSLP), a leading international, award-winning sports nutrition company, recently hosted the National Strength and Conditioning Association (NSCA) Colorado State Clinic which featured leading U.S. researchers and speakers including Dr. Jordan Moon, Colorado State Director, NSCA and Dr. Eric Serrano, Chief Medical Officer, of MusclePharm and Director of the company's Research Institute.
LEVI & KORSINSKY, LLP Notifies Investors of BIOZONE PHARMACEUTICALS, INC. of Claims of Breaches of Fiduciary Duty by Board of the Company in Connection with the Sale of Assets to MusclePharm Corporation
Business Wire - Tue Nov 19, 12:11PM CST
Levi & Korsinsky notifies investors of Biozone Pharmaceuticals, Inc. ("Biozone" or the "Company") (Nasdaq: BZNE) of possible breaches of fiduciary duty and other violations of state law in connection with the sale of Company assets to MusclePharm Corporation ("MusclePharm") (OTCQB: MSLP).
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Biozone Pharmaceuticals, Inc. Proposed Asset Sale to MusclePharm Corporation
Business Wire - Tue Nov 19, 7:17AM CST
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether the Board of Directors of Biozone Pharmaceuticals, Inc. (Nasdaq: BZNE) breached its fiduciary duties in connection with the Company's proposed sale of assets to MusclePharm Corporation (OTCQB: MSLP).
MusclePharm's Award Winning Amino 1 To Be Available at Costco January 2014
PR Newswire - Tue Nov 19, 6:30AM CST
MusclePharm Corporation (OTCQB: MSLP) a leading international, award-winning sports nutrition company, announced today that its popular Amino 1 recovery and hydration sports drink will be available at 150 Costco locations nationwide mid-January 2014.
MusclePharm Announces Results of Audit Committee Review - No Restatement Required
Marketwire - Fri Nov 15, 6:00AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm", or the "Company"), a leading international, award-winning sports nutrition company, announced today that the Audit Committee of its Board of Directors has reviewed certain matters that are the subject of the SEC investigation disclosed in a Form 8-K filed on September 30, 2013 and concluded that no restatement of prior periods' financial statements is required. The matters reviewed included a loss of $2.1 million recorded in 2011 in regard to settlement of accounts payable, the reserve established for previously disclosed litigation initiated against the Company by William Bossung (the "Bossung Litigation"), six proposed adjustment entries made by the auditors in 2012 which were approved by the Audit Committee (the effect of which were below the materiality threshold of the audit) and not made by the Company in that year, and the amounts disclosed as executive perquisites in the Annual Reports on Form 10-K for the fiscal years ended 2010, 2011 and 2012.
MusclePharm Third Quarter Gross Sales Increased 51% to a Record $31.1 Million
Marketwire - Thu Nov 14, 3:23PM CST
MusclePharm Corporation (OTCQB: MSLP) (the "Company", or "MusclePharm"), a leading international, award-winning sports nutrition company, announced today its financial results for the third quarter ended September 30, 2013 ("Q3 2013").
Exclusive Insight on ITEN, MSLP and AMBS
ACCESSWIRE - Thu Nov 14, 3:20AM CST
CodeSmart Holdings, Inc. (OTC:ITEN), Muscle Pharm Corp. (OTC:MSLP) and Amarantus Bioscience Holdings, Inc (OTC:AMBS) have been added to our watch list.
Biozone Announces First Step in Strategic Transition
Marketwire - Wed Nov 13, 2:19PM CST
Biozone Pharmaceuticals, Inc. (OTCQB: BZNE), a manufacturer of over-the-counter (OTC) pharmaceuticals, and skin care, cosmetic and beauty products, and developer of proprietary drug delivery platforms, issued the following Letter to Shareholders from Elliot Maza, Chief Executive Officer and CFO of the company.
MusclePharm to Acquire BioZone Pharmaceuticals' QuSomes(R) Technology and Manufacturing Facilities
Marketwire - Wed Nov 13, 7:03AM CST
MusclePharm Corporation (OTCQB: MSLP) ("MusclePharm"), a leading international, award-winning sports nutrition company, announced today it has signed a definitive asset purchase agreement with BioZone Pharmaceuticals, Inc. ("BioZone") to acquire substantially all of the assets of BioZone and its subsidiaries.
